Your browser doesn't support javascript.
loading
An antisense RNA capable of modulating the expression of the tumor suppressor microRNA-34a.
Serviss, Jason T; Andrews, Nathanael; Van den Eynden, Jimmy; Richter, Felix Clemens; Houtman, Miranda; Vesterlund, Mattias; Schwarzmueller, Laura; Johnsson, Per; Larsson, Erik; Grandér, Dan; Pokrovskaja Tamm, Katja.
Affiliation
  • Serviss JT; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, SE-17177, Sweden. jason.serviss@ki.se.
  • Andrews N; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, SE-17177, Sweden.
  • Van den Eynden J; Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, SE-405 30, Gothenburg, Sweden.
  • Richter FC; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, SE-17177, Sweden.
  • Houtman M; Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Drive, Oxford, OX3 7FY, UK.
  • Vesterlund M; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, SE-17177, Sweden.
  • Schwarzmueller L; Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Johnsson P; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, SE-17177, Sweden.
  • Larsson E; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, SE-17177, Sweden.
  • Grandér D; Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center, Amsterdam, The Netherlands.
  • Pokrovskaja Tamm K; Ludwig Institute for Cancer Research, Stockholm, Sweden.
Cell Death Dis ; 9(7): 736, 2018 07 03.
Article in En | MEDLINE | ID: mdl-29970884
ABSTRACT
The microRNA-34a is a well-studied tumor suppressor microRNA (miRNA) and a direct downstream target of TP53 with roles in several pathways associated with oncogenesis, such as proliferation, cellular growth, and differentiation. Due to its broad tumor suppressive activity, it is not surprising that miR34a expression is altered in a wide variety of solid tumors and hematological malignancies. However, the mechanisms by which miR34a is regulated in these cancers is largely unknown. In this study, we find that a long noncoding RNA transcribed antisense to the miR34a host gene, is critical for miR34a expression and mediation of its cellular functions in multiple types of human cancer. We name this long noncoding RNA lncTAM34a, and characterize its ability to facilitate miR34a expression under different types of cellular stress in both TP53-deficient and wild-type settings.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Antisense / MicroRNAs Limits: Humans Language: En Journal: Cell Death Dis Year: 2018 Document type: Article Affiliation country: Sweden

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Antisense / MicroRNAs Limits: Humans Language: En Journal: Cell Death Dis Year: 2018 Document type: Article Affiliation country: Sweden